Skip to main content
ConductScienceScienceDex

Daniela Salvemini

NIH Rank #2314
Unclaimed recordClaim profile
  • R01 Holder
  • Translational
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 8526936Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Pharmacology
  • OTHER BASIC SCIENCES

NIH Funding · FY2024

Linked Award Amount
$3.2M
Full award amounts, FY2024
Award Records
5
Records listing this PI
Award-Linked Rank
#2,314
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Daniela Salvemini. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Daniela Salvemini as a PI. Multi-PI records show the full award amount for context.

  • 1R61NS138976-01R61
    Development of selective GPR34 antagonists for the treatment of neuropathic pain
    Saint Louis University
    $1.5M
    award amount
  • 1R01NS138127-01R01
    Molecular basis for functional S1PR1 antagonists in the treatment of comorbid migraine and temporomandibular disorders
    University of Maryland Baltimore
    $620.3K
    award amount
  • 5R01CA261979-03R01
    Fingolimod and Ozanimod for the treatment and prevention of chemobrain
    Saint Louis University
    $458.8K
    award amount
  • 5R01NS120930-03R01
    Molecular basis for adenosine A3 receptor agonists in the treatment of migraine
    University of Maryland Baltimore
    $458.7K
    award amount
  • 5R21CA277436-02R21
    GPR160 antibody development for cancer treatment
    Saint Louis University
    $168.2K
    award amount

Award organizations

Organizations that administered FY2024 awards listing Daniela Salvemini as a PI.

Saint Louis University
MO
$2.1M
3 grants
University of Maryland Baltimore
MD
$1.1M
2 grants

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Saint Louis University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #2314
  6. 2024
    Entered Top 25% Nationally
    Ranked #2314
  7. 2025
    $5M Cumulative Funding
  8. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  9. 2025
    R01 Grant Holder

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Daniela Salvemini.

Simon Akerman
University of Maryland Baltimore
5
shared awards
Christopher K Arnatt
Saint Louis University
3
shared awards
Susan A Farr
Saint Louis University
3
shared awards
Marcela Romero-reyes
University of Maryland Baltimore
2
shared awards
John K. Walker
Saint Louis University
1
shared award

Explore further

Find collaborators for Daniela Salvemini

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →